Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Hematology · Congenital Sideroblastic Anemia

Managing Iron Overload and Long-Term Monitoring

At a Glance

Children with congenital sideroblastic anemia can develop excess iron from increased gut absorption and transfusions, sometimes before the first transfusion. Ferritin, liver and heart MRI, and closely monitored chelation help protect organs.

Managing Congenital Sideroblastic Anemia (CSA) requires a lifelong commitment to monitoring the iron in your child’s body. While iron is necessary for life, the body has no natural way to get rid of excess amounts [1]. In CSA, iron builds up not just from transfusions, but also because the ineffective red blood cell production in the bone marrow suppresses a hormone called hepcidin. This causes the gut to absorb excess iron from food [2][3]. Never start iron supplements or vitamins containing iron without explicit instruction from your hematologist.

The Two Sources of Iron Overload

Unlike other anemias where iron overload only happens after many transfusions, children with severe CSA—especially the SLC25A38 type—can have high iron levels even before their very first transfusion [4][5].

  • Source 1: Increased Gut Absorption: The suppressed hepcidin leaves the “doors” to iron absorption wide open in the intestines [1][3].
  • Source 2: Transfusions: Each bag of blood contains a concentrated amount of iron. Over time, this iron builds up in the liver, heart, and endocrine glands [1][6].

Tools for Monitoring Iron

Your specialist will use several tools to track where iron is settling in your child’s body:

  • Serum Ferritin: This blood test provides a rough estimate of total body iron. While helpful for tracking trends, it can be falsely elevated by fevers or inflammation, so it is evaluated alongside other tests [7][6].
  • Liver Iron Concentration (LIC) MRI: This is the most accurate way to measure how much iron is in the liver [6]. It guides when to start or adjust chelation.
  • Cardiac T2 MRI*: This specialized MRI checks for iron in the heart [6]. Finding iron here prompts a prompt review and adjustment of the treatment plan by the specialist team [8].

Iron Chelation Therapy

To remove excess iron, doctors prescribe medications called chelators, such as deferasirox [7][5]. These drugs bind to iron in the blood and organs so it can be passed out of the body through urine or stool [5].

Initiating chelation in an infant is a complex decision. Choice, dose, and timing depend heavily on the infant’s age, weight, transfusion exposure, measured organ iron, and kidney/liver function. Chelators themselves carry risks, including serious renal, hepatic, and gastrointestinal complications. Your care team will require strict, regular blood tests to monitor kidney and liver function while on these medications.


Urgent Medical Care and Red Flags

Because CSA and its syndromic forms can affect multiple systems, you must have a clear, personalized emergency plan.

Go to the Emergency Room IMMEDIATELY if you notice:

  • Fever in an Infant: For an infant under 3 months, a rectal temperature of 38.0°C (100.4°F) or higher requires immediate medical assessment. Discuss age-appropriate fever rules with your doctor.
  • Respiratory Distress: Worsening breathlessness, very fast breathing, “grunting,” or flaring nostrils in any child is a medical emergency [8][9].
  • Severe Lethargy or Pallor: If your child is extremely difficult to wake, floppy, or noticeably paler than their baseline, do not wait for a clinic callback.
  • Signs of Sepsis: Especially in syndromic forms with immunodeficiency (like TRNT1), a high fever accompanied by shaking chills, extreme fussiness, or cold hands and feet must be treated rapidly [10][11].

Call the Hematology Clinic Today if you notice:

  • Poor Feeding: Your child is consistently struggling to feed over a 24-hour period.
  • New Jaundice or Dark Urine: While non-specific, these can indicate liver stress, rapid red blood cell breakdown, or medication side effects.

Common questions in this guide

Can iron overload happen before my child receives a blood transfusion?
Yes. In severe congenital sideroblastic anemia, ineffective red blood cell production can lower hepcidin, a hormone that normally limits iron absorption from the gut. This can cause iron to build up before the first transfusion, especially in SLC25A38-related disease.
Which tests show whether my child's body has too much iron?
Ferritin is a blood test that helps track overall iron trends, but fever or inflammation can raise it. A liver iron concentration MRI measures iron in the liver more accurately, and a cardiac T2* MRI checks for iron in the heart.
When might chelation therapy start for a child with congenital sideroblastic anemia?
The hematology team considers age, weight, transfusion exposure, measured organ iron, and kidney and liver function. There is no single starting point for every infant, so the dose and timing are individualized.
What should we know about deferasirox monitoring?
Deferasirox binds excess iron so it can leave the body in urine or stool. It can affect the kidneys, liver, or gastrointestinal tract, so regular blood tests and follow-up are needed.
When should I take my child with congenital sideroblastic anemia to the emergency room?
For an infant younger than 3 months, a rectal temperature of 38.0°C (100.4°F) or higher requires immediate medical assessment. Respiratory distress, severe difficulty waking, unusual floppiness, marked pallor, or fever with shaking chills and cold hands or feet also requires urgent emergency care.
Could a syndromic form of congenital sideroblastic anemia require other specialists?
Yes, depending on the genetic form and symptoms, the care team may involve specialists such as a cardiologist or immunologist. This can be especially important when the condition has immune or heart-related concerns, and the hematology team should coordinate the follow-up schedule.

Get notified when new evidence is published on Severe congenital hypochromic anemia with ringed sideroblasts.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Pathophysiology and classification of iron overload diseases; update 2018.

    Brissot P, Troadec MB, Loréal O, Brissot E

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.

    PMID: 30173950
  2. 2

    Iron Metabolism in the Disorders of Heme Biosynthesis.

    Ricci A, Di Betto G, Bergamini E, et al.

    Metabolites 2022; (12(9)) doi:10.3390/metabo12090819.

    PMID: 36144223
  3. 3

    Hepcidin and Anemia: A Tight Relationship.

    Pagani A, Nai A, Silvestri L, Camaschella C

    Frontiers in physiology 2019; (10()):1294 doi:10.3389/fphys.2019.01294.

    PMID: 31649559
  4. 4

    Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.

    Uminski K, Houston DS, Hartley JN, et al.

    Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.

    PMID: 32790119
  5. 5

    Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

    Cazzola M, Malcovati L

    Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.

    PMID: 26637696
  6. 6

    Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

    Le Rouzic MA, Fouquet C, Leblanc T, et al.

    Blood cells, molecules & diseases 2017; (66()):11-18 doi:10.1016/j.bcmd.2017.07.003.

    PMID: 28772256
  7. 7

    A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.

    Cai J, Liu T, Huang Y, et al.

    Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.

    PMID: 39281190
  8. 8

    Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.

    Sommerville EW, Ng YS, Alston CL, et al.

    JAMA neurology 2017; (74(6)):686-694 doi:10.1001/jamaneurol.2016.4357.

    PMID: 28395030
  9. 9

    Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variants.

    Rudaks LI, Watson E, Oboudiyat C, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2226-2230 doi:10.1002/ajmg.a.62755.

    PMID: 35393742
  10. 10

    Prognostic Factors for Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fevers, and Developmental Delay Due to TRNT1 Gene Mutations: A Case Report and Systematic Review.

    Su TH, Lee NC, Wang LC, et al.

    Journal of clinical immunology 2026; (46(1)).

    PMID: 41795040
  11. 11

    Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.

    Giannelou A, Wang H, Zhou Q, et al.

    Annals of the rheumatic diseases 2018; (77(4)):612-619 doi:10.1136/annrheumdis-2017-212401.

    PMID: 29358286

This page is for informational purposes only and does not constitute medical advice. For a child with congenital sideroblastic anemia, the hematology team must individualize iron testing, MRI timing, chelation, and emergency care.